Distinct expression of immunoglobulin-binding proteins in shiga toxin-producing Escherichia coli implicates high protein stability and a characteristic phenotype

Toxins

Volumn 9, Issue 5, 2017, Pages

  Rubin, Dennis ^a   Zhang, Wenlan ^a   Karch, Helge ^a   Kuczius, Thorsten ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Expression; Immunoglobulin binding protein G; Regulation; Shiga toxin producing Escherichia coli

Indexed keywords

IMMUNOGLOBULIN BINDING PROTEIN G; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; ESCHERICHIA COLI PROTEIN; IMMUNOGLOBULIN-BINDING FACTORS; LYMPHOKINE;

ARTICLE; BACTERIAL GROWTH; CORRELATION ANALYSIS; IMMUNOBLOTTING; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; NONHUMAN; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN STABILITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; METABOLISM;

ESCHERICHIA COLI PROTEINS; LYMPHOKINES; PHENOTYPE; PROTEIN STABILITY; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 85019027776     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins9050153     Document Type: Article

References (32)

1. Bouvet, J.P. Immunoglobulin Fab fragment-binding proteins. Int. J. Immunopharmacol. 1994, 16, 419–424. [CrossRef]
2. Sandt, C.H.; Wang, Y.-D.; Wilson, R.A.; Hill, C.W. Escherichia coli strains with nonimmune immunoglobulin-binding activity. Infect. Immun. 1997, 65, 4572–4579. [PubMed]
3. Sandt, C.H.; Hill, C.W. Four different genes responsible for nonimmune immunoglobulin-binding activities within a single strain of Escherichia coli. Infect. Immun. 2000, 68, 2205–2214. [CrossRef] [PubMed]
4. Ochman, H.; Selander, R.K. Standard reference strains of Escherichia coli from natural populations. J. Bacteriol. 1984, 157, 690–693. [PubMed]
5. Sandt, C.H.; Hill, C.W. Nonimmune binding of human immunoglobulin A (IgA) and IgG Fc by distinct sequence segments of the EibF cell surface protein of Escherichia coli. Infect. Immun. 2001, 69, 7293–7303. [CrossRef] [PubMed]
6. Bardiau, M.; Grégoire, F.; Muylaert, A.; Nahayo, A.; Duprez, J.N.; Mainil, J.; Linden, A. Enteropathogenic (EPEC), enterohemorrhagic (EHEC) and verotoxigenic (VTEC) Escherichia coli in wild cervids. J. Appl. Microbiol. 2010, 109, 2214–2222. [CrossRef] [PubMed]
7. Merkel, V.; Ohder, B.; Bielaszewska, M.; Zhang, W.; Fruth, A.; Menge, C.; Borrmann, E.; Middendorf, B.; Müthing, J.; Karch, H.; et al. Distribution and phylogeny of immunoglobulin-binding protein G in Shiga toxin-producing Escherichia coli and its association with adherence phenotypes. Infect. Immun. 2010, 78, 3625–3636. [CrossRef] [PubMed]
8. Kuczius, T.; Zhang, W.; Merkel, V.; Mellmann, A.; Tarr, P.I.; Karch, H. Agitation down-regulates immunoglobulin binding protein EibG expression in Shiga toxin-producing Escherichia coli (STEC). PLoS ONE 2015, 10, e0119583. [CrossRef] [PubMed]
9. Croxen, M.A.; Law, R.J.; Scholz, R.; Keeney, K.M.; Wlodarska, M.; Finlay, B.B. Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev. 2013, 4, 822–880. [CrossRef] [PubMed]
10. Karch, H.; Meyer, T. Evaluation of oligonucleotide probes for identification of Shiga-like-toxin-producing Escherichia coli. J. Clin. Microbiol. 1989, 27, 1180–1186. [PubMed]
11. Bauwens, A.; Betz, J.; Meisen, I.; Kemper, B.; Karch, H.; Müthing, J. Facing glycosphingolipid–Shiga toxin interaction: Dire straits for endothelial cells of the human vasculature. Cell. Mol. Life Sci. 2013, 70, 425–457. [CrossRef] [PubMed]
12. Lee, M.S.; Koo, S.; Jeong, D.G.; Tesh, V.L. Shiga toxins as multi-functional proteins: Induction of host cellular stress responses, role in pathogenesis and therapeutic applications. Toxins 2016, 8, 77. [CrossRef] [PubMed]
13. Betz, J.; Dorn, I.; Kouzel, I.U.; Bauwens, A.; Meisen, I.; Kemper, B.; Bielaszewska, M.; Mormann, M.; Weymann, L.; Sibrowski W.; et al. Shiga toxin of enterohaemorrhagic Escherichia coli directly injures developing human erythrocytes. Cell. Microbiol. 2016, 10, 1339–1348. [CrossRef] [PubMed]
14. Bielaszewska, M.; Sinha, B.; Kuczius, T.; Karch, H. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 2005, 73, 552–562. [CrossRef] [PubMed]
15. Bielaszewska, M.; Stoewe, F.; Fruth, A.; Zhang, W.; Prager, R.; Brockmeyer, J.; Mellmann, A.; Karch, H.; Friedrich, A.W. Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates. J. Clin. Microbiol. 2009, 47, 2061–2066. [CrossRef] [PubMed]
16. Karch, H.; Tarr, P.I.; Bielaszewska, M. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 2005, 295, 405–418. [CrossRef] [PubMed]
17. Brunder, W.; Schmidt, H.; Karch, H. KatP, a novel catalase-peroxidase encoded by the large plasmid of enterohaemorrhagic Escherichia coli O157:H7. Microbiology 1996, 142, 3305–3315. [CrossRef] [PubMed]
18. Brunder, W.; Schmidt, H.; Karch, H. EspP, a novel extracellular serine protease of enterohaemorrhagic Escherichia coli O157:H7 cleaves human coagulation factor V. Mol. Microbiol. 1997, 24, 767–778. [CrossRef] [PubMed]
19. Brockmeyer, J.; Spelten, S.; Kuczius, T.; Bielaszewska, M.; Karch, H. Structure and function relationship of the autotransport and proteolytic activity of EspP from Shiga toxin-producing Escherichia coli. PLoS ONE 2009, 4, e6100. [CrossRef] [PubMed]
20. Bielaszewska, M.; Aldick, T.; Bauwens, A.; Karch, H. Hemolysin of enterohemorrhagic Escherichia coli: Structure, transport, biological activity and putative role in virulence. Int. J. Med. Microbiol. 2014, 304, 521–529. [CrossRef] [PubMed]
21. Bielaszewska, M.; Rüter, C.; Kunsmann, L.; Greune, L.; Bauwens, A.; Zhang, W.; Kuczius, T.; Kim, K.S.; Mellmann, A.; Schmidt, M.A.; et al. Enterohemorrhagic Escherichia coli hemolysin employs outer membrane vesicles to target mitochondria and cause endothelial and epithelial apoptosis. PLoS Pathog. 2013, 9, e1003797. [CrossRef] [PubMed]
22. Lu, Y.; Iyoda, S.; Satou, H.; Satou, H.; Itoh, K.; Saitoh, T.; Watanabe, H. A new immunoglobulin-binding protein, EibG, is responsible for the chain-like adhesion phenotype of locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Immun. 2006, 74, 5747–5755. [CrossRef] [PubMed]
23. Werber, D.; Beutin, L.; Pichner, R.; Stark, K.; Fruth, A. Shiga toxin-producing Escherichia coli-serogroups in food and patients, Germany. Emerg. Infect. Dis. 2008, 14, 1803–1806. [CrossRef] [PubMed]
24. Kendall, M.M.; Gruber, C.C.; Parker, C.T.; Sperandio, V. Ethanolamine controls expression of genes encoding components involved in interkingdom signaling and virulence in enterohemorrhagic Escherichia coli O157:H7. MBio 2012, 3, e00050-12. [CrossRef] [PubMed]
25. Torres, A.G.; Milflores-Flores, L.; Garcia-Gallegos, J.G.; Patel, S.D.; Best, A.; La Ragione, R.M.; Martinez-Laguna, Y.; Woodward, M.J. Environmental regulation and colonization attributes of the long polar fimbriae (LPF) of Escherichia coli O157:H7. Int. J. Med. Microbiol. 2007, 297, 177–185. [CrossRef] [PubMed]
26. Leo, J.C.; Lyskowski, A.; Hattula, K.; Hartmann, M.D.; Schwarz, H.; Butcher, S.J.; Linke, D.; Lupas, A.N.; Goldman, A. The structure of E. coli IgG-binding protein D suggests a general model for bending and binding in trimeric autotransporter adhesins. Structure 2011, 19, 1021–1030. [CrossRef] [PubMed]
27. Munn, C.B.; Ishiguro, E.E.; Kay, W.W.; Trust, T.J. Role of surface components in serum resistance of virulent Aeromonas salmonicida. Infect. Immun. 1982, 36, 1069–1075. [PubMed]
28. Raeder, R.; Boyle, M.D. Properties of IgG-binding proteins expressed by Streptococcus pyogenes isolates are predictive of invasive potential. J. Infect. Dis. 1996, 173, 888–895. [CrossRef] [PubMed]
29. Beachey, E.H. Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J. Infect. Dis. 1981, 143, 325–345. [CrossRef] [PubMed]
30. Sokurenko, E.V.; Courtney, H.S.; Abraham, S.N.; Klemm, P.; Hasty, D.L. Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect. Immun. 1992, 60, 4709–4719. [PubMed]
31. Markwell, M.A.; Haas, S.M.; Bieber, L.L.; Tolbert, N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978, 87, 206–210. [CrossRef]
32. Kuczius, T.; Koch, R.; Keyvani, K.; Karch, H.; Grassi, J.; Groschup, M.H. Regional and phenotype heterogeneity of cellular prion proteins in the human brain. Eur. J. Neurosci. 2007, 25, 2649–2655. [CrossRef] [PubMed]